Crossmark

Survival analysis and predictors for hemoglobin level and time-to-default from HIV treatment among first-line female HIV-positive patients within the reproductive age group

Crossref DOI link: https://doi.org/10.1038/s41598-025-00033-2

Published Online: 2025-05-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muhie, Nurye Seid

Tegegne, Awoke Seyoum
License Information

Text and Data Mining valid from 2025-05-02

Version of Record valid from 2025-05-02
More Information

Article History

Received: 19 September 2024

Accepted: 24 April 2025

First Online: 2 May 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: A statement to confirm that all methods were performed by the ethical standards as laid down in the Declaration of Helsinki. Hence, informed consent was waived by the Bahir Dar University research technical and ethical review board with Clinical Trial Number Stat-S/166/2022 because of retrospective nature of the study. The study was approved by the Bahir Dar University Research Technical and Ethical Review Board.

Document is current

Any future updates will be listed below